投资者
广州是中国最大、最繁荣的城市之一，拥有先进的医疗体系，一大批综合性大学以及三甲附属医院。随着生物技术产业的不断发展，广州拥有合适的基础设施来支持那些在中国寻求本地或多中心临床试验的国际公司。
中以基金在广州与政府建立了稳固高效的合作关系，得到了广州市政府和开发区的大力支持，是其在广州的战略合作伙伴和主要投资方。由于拥有多家永久性国有企业作为其有限合伙人，中以基金在促进跨国投资国际生物技术公司方面具有独特的地位。
Guangzhou Industrial Investment Fund
An investment fund sponsored by the GZ municipal government, with total capital under management above 170 billion RMB.
The fund is targeting strategic industries which are important to the development of GZ economy, engaging in government funding, private equity, angel funds, venture capital, pre-IPO, PIPE, M&A, municipal development funds, internet financing, fixed income, and other financial businesses.
Guangzhou Pharmaceuticals Company
GPC is one of the largest pharmaceutical companies in China with over 87.8 billion RMB in sales in 2016, over 30 subsidiaries, including public companies and well-known brands, including Wanglaoji (108 billion RMB brand value), Baiyunshan (28 billion RMB brand value), and Chenliji.
GPC is developing 4 main sectors: healthcare (mainly nutrition), medicine (Chinese and western drugs), logistics and healthcare services. Its medicine sector includes traditional Chinese medicine, botanical medicine, chemical pharmaceutical materials and preparation, biological preparation by focusing medical treatments in cardiovascular, respiratory, digestive system, diabetes, rabies.
http://en.gpc.com.cn/
Guangzhou International Bio-Island
The company is full subsidiary of The Guangzhou Development District Industry Group, which is under jurisdiction of Guangzhou Development District Administration. It is managing a modern life science town in the heart of Guangzhou, including research, industrial, living, and commerce infrastructure, life sciences companies, skilled personnel and information systems, full government, business, and living services.
http://www.bio-island.com/en/Park.aspx